Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis

AIM: Cystic fibrosis (CF) patients are at high risk of developing CF-related diabetes (CFRD). In non-CF patients, liver disease, specifically steatosis and non-alcoholic fatty liver disease (NAFLD), is strongly associated with type 2 diabetes. We compared glycemic status and metabolic profiles in CF...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Colomba, Johann, Netedu, Silvia R., Lehoux-Dubois, Catherine, Coriati, Adèle, Boudreau, Valérie, Tremblay, François, Cusi, Kenneth, Rabasa-Lhoret, Rémi, Leey, Julio A.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6638946/
https://ncbi.nlm.nih.gov/pubmed/31318914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0219855
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados